Advanced search
Start date
Betweenand

Immune-checkpoint inhibitors: immunophenotyping and clinical outcome to predict response at Barretos Cancer Hospital

Grant number: 21/04100-6
Support Opportunities:Scholarships in Brazil - Young Researchers
Start date: May 01, 2021
End date: April 30, 2025
Field of knowledge:Health Sciences - Medicine - Surgery
Principal Investigator:Lidia Maria Rebolho Batista Arantes
Grantee:Lidia Maria Rebolho Batista Arantes
Host Institution: Hospital do Câncer de Barretos. Fundação Pio XII (FP). Barretos , SP, Brazil
Associated research grant:19/07111-9 - Immune-checkpoint inhibitors: immunophenotyping and clinical outcome to predict response at Barretos Cancer Hospital, AP.JP
News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SORROCHE, BRUNA PEREIRA; TEIXEIRA, RENAN DE JESUS; PEREIRA, CAIO AUGUSTO DANTAS; SANTANA, IARA VIANA VIDIGAL; VUJANOVIC, LAZAR; VAZQUEZ, VINICIUS DE LIMA; ARANTES, LIDIA MARIA REBOLHO BATISTA. PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in Brazil. DIAGNOSTICS, v. 13, n. 6, p. 11-pg., . (19/03570-9, 21/04100-6, 19/07111-9, 21/10922-9)
TOSTES, KATIANE; SIQUEIRA, ALEXIA POLO; REIS, RUI MANUEL; LEAL, LETICIA FERRO; ARANTES, LIDIA MARIA REBOLHO BATISTA. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 24, n. 15, p. 18-pg., . (21/08352-0, 21/04100-6, 19/07111-9)